Cryotherapy for Preventing Chemotherapy-induced Neuropathy: Proven, Promising-appearing, or Hogwash? - SPOC

Chemotherapy-induced neuropathy is a major clinical problem that can lead to persistent issues for cancer survivors and can even limit the use of planned chemotherapy treatment during the course of care. Cryotherapy is already an established treatment for other chemotherapy induced conditions such as alopecia and mouth mucositis. This course will explore the evidence for using this low-cost intervention to reduce the incidence/severity of chemotherapy-induced neuropathy.

Target Audience

These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, registered nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, allied health personnel, and others who are interested in care for patients and survivors in North Carolina.

Learning Objectives

  • Discuss the current guidelines for the treatment of chemotherapy-induced neuropathy.
  • Identify examples of successful use cases of cryotherapy treatments in other chemotherapy related conditions.
  • Evaluate the current evidence supporting the use of cryotherapy to treat chemotherapy-induced neuropathy.

Handouts

 

Taking the Course

To continue, click the button Take Course.

If you do not see the button, please ensure that you are logged in. If you are logged in and still don't see the button, please contact us at [email protected] or (919) 445–1000.

Course summary
Available credit: 
  • 1.00 Participation
Course opens: 
05/06/2022
Course expires: 
12/31/2028
Photo of Charles Loprinzi, MD 

Charles Loprinzi, MD

Medical Oncologist
Mayo Clinic
 

 

This Non-Credit Course does not have accreditation. It only offers general participation certificates.

Available Credit

  • 1.00 Participation
Please login or register to take this course.